Multidisciplinary support for adults living with obesity
Part of Hormones & metabolism clinical trials.
This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- Your body mass index (BMI) is 30 or higher
- You are not pregnant at the start of the study
- You have not had weight-loss surgery in the past
- You have not taken weight-loss medication in the last 90 days
- You are willing to attend regular follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests a small implant placed under the skin that slowly releases semaglutide, a medication that helps with weight management. It's for people who are overweight but do not have diabetes.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Obesity Difficult Airway Airway Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.